Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyReferences
- Epidemiology and prognostic implications of contrast-induced nephropathy.Am J Cardiol. 2006; 98: 5K-13K
- Risk prediction of contrast-induced nephropathy.Am J Cardiol. 2006; 98: 27K-36K
- Hospital-acquired renal insufficiency: a prospective study.Am J Med. 1983; 74: 243-248
- Hospital-acquired renal insufficiency.Am J Kidney Dis. 2002; 39: 930-936
Laskey W, ed. Contrast-induced nephropathy. clinical insights and practical guidance. A report from the CIN consensus working panel. Am J Cardiol 2006;98(suppl):1K–77K.
FDA ALERT [06/2006]: Development of serious and sometimes fatal nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy. Available at: http://www.fda.gov/cder/drug/InfoSheets/HCP/gccaHCP.htm. Accessed May 1, 2007.
Article Info
Publication History
Footnotes
This manuscript is based on a meeting of the authors on April 10, 2007